If the FDA agrees, a dose of Pfizer’s bivalent omicron-targeting vaccine would be substituted for the third shot for children ages 6 months through 4 years.
: Just 2% of tots under 2 and about 4% of 2- to 4-year-olds have gotten their primary doses so far, according to the Centers for Disease Control and Prevention. Those combination shots contain half the original vaccine and half tweaked to match the BA.4 and BA.5 omicron strains that until recently were dominant. Now BA.5 descendants are responsible for most COVID-19 cases.
showing that an updated booster, using either company’s version, does offer added protection to adults. The analysis found the greatest benefit was in people who’d never had a prior booster, just two doses of the original COVID-19 vaccine -- but that even those who’d had a summertime dose were more protected than if they’d skipped the newest shot.The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer/BioNTech seek FDA authorization of updated Covid-19 vaccine for children under 5 | CNNPfizer and BioNTech have submitted an application to the US Food and Drug Administration for their updated Covid-19 vaccine to be used as the third shot in the three-dose primary vaccine series for children ages 6 months through 4 years.
Read more »
Pfizer, BioNTech ask FDA to authorize bivalent COVID vaccine in young childrenPfizer Inc. undefined and BioNTech SE undefined said Monday that they asked the Food and Drug Administration to authorize their updated COVID-19 vaccine as...
Read more »
Pfizer asks FDA to clear updated COVID shot for kids under 5Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5.
Read more »
Pfizer asks FDA to clear updated COVID shot for kids under 5Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 — not as a booster but part of their initial shots. Children ages 6 months through 4 years already are supposed to get three extra-small doses of the original Pfizer COVID-19 vaccine — each a tenth of the amount adults receive — as their primary series.
Read more »
Pfizer asks FDA to clear updated COVID shot for kids under 5Pfizer and its partner BioNTech said Monday that may help prevent severe illness and hospitalization from COVID-19 in little kids, at a time when children’s hospitals already are packed with youngsters hit by other respiratory illnesses.
Read more »
FDA Pulls US Authorization for Eli Lilly's COVID Drug BebtelovimabEli Lilly's COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, the Food and Drug Administration said, citing it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.
Read more »